Your browser doesn't support javascript.
loading
A CCR5 antagonist-based HIV entry inhibitor exhibited potent spermicidal activity: Potential application for contraception and prevention of HIV sexual transmission.
Yang, Mingjun; Zhi, Ruina; Lu, Lu; Dong, Mingxin; Wang, Yuzhu; Tian, Fang; Xia, Minjie; Hu, Jingying; Dai, Qiuyun; Jiang, Shibo; Li, Weihua.
Afiliación
  • Yang M; Key Laboratory of Reproduction Regulation of National Population and Family Planning Commission, Shanghai Institute of Planned Parenthood Research, Institute of Reproduction and Development, Fudan University, People's Republic of China.
  • Zhi R; Key Laboratory of Reproduction Regulation of National Population and Family Planning Commission, Shanghai Institute of Planned Parenthood Research, Institute of Reproduction and Development, Fudan University, People's Republic of China.
  • Lu L; Key Laboratory of Medical Molecular Virology of MOE/MOH, School of Basic Medical Sciences, Fudan University, Shanghai, People's Republic of China.
  • Dong M; Beijing Institute of Biotechnology, Beijing, People's Republic of China.
  • Wang Y; Key Laboratory of Reproduction Regulation of National Population and Family Planning Commission, Shanghai Institute of Planned Parenthood Research, Institute of Reproduction and Development, Fudan University, People's Republic of China.
  • Tian F; Key Laboratory of Reproduction Regulation of National Population and Family Planning Commission, Shanghai Institute of Planned Parenthood Research, Institute of Reproduction and Development, Fudan University, People's Republic of China.
  • Xia M; Key Laboratory of Reproduction Regulation of National Population and Family Planning Commission, Shanghai Institute of Planned Parenthood Research, Institute of Reproduction and Development, Fudan University, People's Republic of China.
  • Hu J; Key Laboratory of Reproduction Regulation of National Population and Family Planning Commission, Shanghai Institute of Planned Parenthood Research, Institute of Reproduction and Development, Fudan University, People's Republic of China.
  • Dai Q; Beijing Institute of Biotechnology, Beijing, People's Republic of China.
  • Jiang S; Key Laboratory of Reproduction Regulation of National Population and Family Planning Commission, Shanghai Institute of Planned Parenthood Research, Institute of Reproduction and Development, Fudan University, People's Republic of China; Key Laboratory of Medical Molecular Virology of MOE/MOH, School
  • Li W; Key Laboratory of Reproduction Regulation of National Population and Family Planning Commission, Shanghai Institute of Planned Parenthood Research, Institute of Reproduction and Development, Fudan University, People's Republic of China. Electronic address: weihua.li@sippr.org.cn.
Eur J Pharm Sci ; 117: 313-320, 2018 May 30.
Article en En | MEDLINE | ID: mdl-29496533
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperazinas / Espermicidas / Espermatozoides / Infecciones por VIH / Receptores CCR5 / Inhibidores de Fusión de VIH / Antagonistas de los Receptores CCR5 Límite: Animals / Female / Humans / Male / Pregnancy Idioma: En Revista: Eur J Pharm Sci Asunto de la revista: FARMACIA / FARMACOLOGIA / QUIMICA Año: 2018 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperazinas / Espermicidas / Espermatozoides / Infecciones por VIH / Receptores CCR5 / Inhibidores de Fusión de VIH / Antagonistas de los Receptores CCR5 Límite: Animals / Female / Humans / Male / Pregnancy Idioma: En Revista: Eur J Pharm Sci Asunto de la revista: FARMACIA / FARMACOLOGIA / QUIMICA Año: 2018 Tipo del documento: Article Pais de publicación: Países Bajos